Why the study?
Does a modified competitive binding radioimmunoassay accurately detect and differentiate acute and convalescent anti-hepatitis A virus antibodies compared to standard solid-phase radioimmunoassay?
Does a modified competitive binding radioimmunoassay accurately detect and differentiate acute and convalescent anti-hepatitis A virus antibodies compared to standard solid-phase radioimmunoassay?
A modified competitive binding radioimmunoassay can accurately detect and differentiate acute (IgM) and convalescent (IgG) hepatitis A virus antibodies.
Answers are grounded in this paper and cite their sources.
May aid acute HAV serodiagnosis; leaves open routine adoption pending modern assay comparisons.
A competitive binding radioimmunoassay (CBA) for antibody to hepatitis A virus (HAV) was evaluated and compared with a standard solid-phase radioimmunoassay for anti-HAV, CBA was found to be sensitive and specific for the detection of anti-HAV, as demonstrated by the 98% concordance of CBA and solid-phase radioimmunoassay test results. The standard CBA test was modified for the differential detection of acute (immunoglobulin M) and convalescent (immunoglobulin G) anti-HAV by incorporation of a step in which immunoglobulin G anti-HAV was preferentially absorbed with S. aureus cells (protein A). The modified CBA test was shown to be capable of differentiating between acute- and convalescent-phase sera. The modified CBAM test was able to detect immunoglobulin M anti-HAV up to approximately 4 weeks after the onset of illness.
No takes yet. Share an insight, caveat, or question.
Bradley et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: